<code id='FA9FDCA67E'></code><style id='FA9FDCA67E'></style>
    • <acronym id='FA9FDCA67E'></acronym>
      <center id='FA9FDCA67E'><center id='FA9FDCA67E'><tfoot id='FA9FDCA67E'></tfoot></center><abbr id='FA9FDCA67E'><dir id='FA9FDCA67E'><tfoot id='FA9FDCA67E'></tfoot><noframes id='FA9FDCA67E'>

    • <optgroup id='FA9FDCA67E'><strike id='FA9FDCA67E'><sup id='FA9FDCA67E'></sup></strike><code id='FA9FDCA67E'></code></optgroup>
        1. <b id='FA9FDCA67E'><label id='FA9FDCA67E'><select id='FA9FDCA67E'><dt id='FA9FDCA67E'><span id='FA9FDCA67E'></span></dt></select></label></b><u id='FA9FDCA67E'></u>
          <i id='FA9FDCA67E'><strike id='FA9FDCA67E'><tt id='FA9FDCA67E'><pre id='FA9FDCA67E'></pre></tt></strike></i>

          Home / Wikipedia / comprehensive

          comprehensive


          comprehensive

          author:fashion    Page View:19
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In